investors.innocoll.com investors.innocoll.com

investors.innocoll.com

Innocoll | Investor Relations | Investor Relations Home

Innocoll management team have experience in the pharmaceutical industry in the US and Europe with a proven track record of development and commercialization of a number of significant drug delivery products across a wide variety of delivery routes.

http://investors.innocoll.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR INVESTORS.INNOCOLL.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

January

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Sunday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 4.2 out of 5 with 11 reviews
5 star
8
4 star
1
3 star
0
2 star
0
1 star
2

Hey there! Start your review of investors.innocoll.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

1.7 seconds

CONTACTS AT INVESTORS.INNOCOLL.COM

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

SCORE

6.2

PAGE TITLE
Innocoll | Investor Relations | Investor Relations Home | investors.innocoll.com Reviews
<META>
DESCRIPTION
Innocoll management team have experience in the pharmaceutical industry in the US and Europe with a proven track record of development and commercialization of a number of significant drug delivery products across a wide variety of delivery routes.
<META>
KEYWORDS
1 Innocoll pharmaceuticals
2 CollaRX
3 CollaFilm
4 CollaPress
5 LiquiColl
6 biocompatible collagen
7 biodegradable collagen
8 type 1 collagen
9 surgical wound infections
10 adjuvant treatment Diabetic foot
CONTENT
Page content here
KEYWORDS ON
PAGE
skip to navigation,skip to content,innocoll inc,navigation,about us,senior management,manufacturing,locations,our products,our technologies,partnering,investors,investor home,news and events,share performance,sec filings,corporate governance,analysts,news
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Innocoll | Investor Relations | Investor Relations Home | investors.innocoll.com Reviews

https://investors.innocoll.com

Innocoll management team have experience in the pharmaceutical industry in the US and Europe with a proven track record of development and commercialization of a number of significant drug delivery products across a wide variety of delivery routes.

SOCIAL ENGAGEMENT



OTHER SITES

investors.inb.com investors.inb.com

IRWeblink

Thank you for your interest in IR Solutions. You have reached this page because the URL you have requested is no longer available, or you do not have permission to view it. For more information on the most comprehensive IR web site management tool available, please click here. If you have any questions, e-mail [email protected]. Or call (866) 802-9128 and ask for an IR Solutions sales representative. To return to the main SNL Financial homepage.

investors.incitecpivot.com.au investors.incitecpivot.com.au

Incitec Pivot - Investor Centre - Investor Home

Skip to main content. Incitec Pivot Limited is an industrial chemicals manufacturer supplying the agriculture and mining industries. Visit Incitec Pivot Limited. Dyno Nobel is a leading supplier of industrial explosives and blasting services to the mining, quarrying, seismic and construction industries. Visit Dyno Nobel here. Incitec Pivot plays a leading role in the manufacture and supply of fertiliser to farmers in Australia's eastern and southern States. Visit Incitec Pivot Fertilisers here.

investors.infinera.com investors.infinera.com

Infinera Corporation | Investor Relations | Overview

Research and Education Networks. Infinera in the Community. At Infinera, we are redefining optical networking. Infinera is enabling network operators to deliver vast amounts of bandwidth with greater ease. Whether for the long-haul core, metro, or emerging high-capacity metro cloud, Infinera Intelligent Transport Networks help carriers exploit the increasing demand for cloud-based services and datacenter connectivity as they advance into the Terabit Era. 160;  0.26. 08/14/15 4:00 pm ET. SUNNYVALE, CA - (...

investors.info investors.info

investors.info is for sale!

Investors.info is for sale! Your offer in USD. A domain name like Investors.info has all the characteristics of a great domain. See the listing. An aged domain like Investors.info can improve search engine rankings and boost your brand. Domains that include search keywords position your brand and boost your search engine presence. Investors.info domain is perfect deliver informative content to users. This domain is available and ready to be used now!

investors.inin.com investors.inin.com

Investor Relations - Interactive Intelligence, Inc.

Call Us: 1 800.267.1364. Sign up for Collaborate. CIC for Unified Communications. Interaction Supervisor, iPad Edition. Chat Live with Us. Available during 8am - 5pm Eastern. Send us an email. Let us call you back at a time to suit you. Fill in your details on our simple form. Call us: 800.267.1364. Speak to one of our professional team members. Aug 3, 2015. Interactive Intelligence Reports 2015 Second-Quarter and Six Months Financial Results. Jul 23, 2015. View all press releases ».

investors.innocoll.com investors.innocoll.com

Innocoll | Investor Relations | Investor Relations Home

Supervisory and Management Boards. Innocoll AG (Nasdaq: INNL) is a commercial stage specialty pharmaceutical company with multiple late stage development programs targeting areas of significant unmet medical need. All of our products are developed and manufactured using our proprietary collagen-based technology platform. Aug 14, 2015. Innocoll AG Announces Second Quarter 2015 Financial and Operating Results and Updates Late-Stage Product Portfolio Progress. Aug 13, 2015. 160; 1.04. Minimum 20 minute delay.

investors.innovation-group.com investors.innovation-group.com

Investors – Innovation Group

Skip to main content. First Notice of Loss (FNOL). Emergency Tow and Roadside. Subrogation and Adverse Subrogation. Motor Services Online Tracking. Claims Management Services - Property. Fleet Maintain and Comparator. Innovation Group at a Glance. Key Risks and Uncertainties. Rest of Europe Regional Review. South Africa Regional Review. North America Regional Review. Asia Pacific Regional Review. 5 Year Profit and Loss. KPIs and Business Drivers. First Notice of Loss (FNOL). Emergency Tow and Roadside.

investors.inphi.com investors.inphi.com

Investor Relations - Inphi

Inphi Corp at Oppenheimer 18th Annual Technology, Internet and Communications Conference. 160;at 2:25 pm ET. Inphi Corp at Oppenheimer 18th Annual Technology, Internet and Communications Conference. Wednesday, August 12, 2015 . 2:25 pm ET  . Click here for webcast. Click here to add this event to your calendar. Inphi is a leading provider of high-speed, mixed signal semiconductor solutions for the communications and computing markets. Inphi’s solutions provide a vi. 160; 0.62. Minimum 20 minute delay.

investors.installedbuildingproducts.com investors.installedbuildingproducts.com

Installed Building Products Inc. - Investor Relations

Closets & Shelving. Shower Doors, Mirrors & Bath Hardware. Door Locksets & Hardware. Annual Meeting of Stockholders. Stock Quote (NYSE: IBP). 4:02 PM ET on Aug 14, 2015. Delayed at least 20 minutes. View all ». Aug 10, 2015. Installed Building Products Announces the Acquisition of an Insulation Installer with Locations in New Jersey and Texas. Jul 29, 2015. Installed Building Products Reports Results for Second Quarter 2015. Shower Doors, Mirrors and Bath Hardware. Door Locksets and Hardware.

investors.instem.com investors.instem.com

Instem Investor Centre

A global provider of leading software solutions. And services to the life sciences community. Helping our clients bring life enhancing products to market faster. Creating a more connected ecosystem in the. Life sciences industry by consolidating and. Harmonizing a fragmented IT marketplace. Welcome to the Instem Investor Centre. 26 March 2018 - Unaudited Results for the Year Ended 31 December 2017. 26 March 2018 - SEND Contract Extension and SEND Update. A Decade in Perspective. A Decade in Perspective.

investors.insulet.com investors.insulet.com

Investor Relations | Insulet Corporation

Skip to main navigation. SIGN UP FOR ALERTS. IR and Media Contact:. Deborah R. Gordon, C.P.A. Investor Relations and Corporate Communications. 600 Technology Park Dr. Billerica, MA 01821-4150. Stock Quote (: ). Studies have demonstrated the advantages of insulin pump therapy over multiple daily insulin injections (MDI); these advantages include better glycemic control, fewer hypoglycemic events, reduced glycemic variability. And improved quality of life. 1 Diabetes Control and Complications Trial Researc...